Device Trial Radar · NCT06772987
NQ TMS for MDD Therapy Using 1 Day x 3 Sessions Protocol for Adult Patient
Last checked: Nov 19, 2026Latest source record: May 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Jan 16, 2025
Primary completion
May 6, 2025
Study completion May 6, 2025
Sponsor
- Lead sponsor
- NeuroQore Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Makromed Inc.
- First posted
- Jan 14, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Transcranial Magnetic Stimulation (TMS) Therapy is a non-invasive procedure that uses magnetic pulses to stimulate the cortex (brain) to treat Major Depressive Disorder (MDD). Currently established therapy uses one 19-minute treatment session per day for 5 days per week for 6 weeks, for a total of 30 treatment sessions. The goal of this clinical trial is to evaluate the safety and effectiveness of an accelerated but shortened TMS dosing regimen for adults with MDD aged 22-85. Participants in this study will be subjected to the same 19-minutes treatment session, but three times on the same day, and only for one day. This will greatly reduce the logistical burden of completing the therapy regime.
Conditions
- Major Depressive Disorder (MDD)
Interventions
Accelerated rTMS treatmentDevice
1 Day x 3 Sessions of 19-minutes rTMS treatment, with 60 minutes rest between sessions.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Montgomery-Åsberg Depression Rating Scale (MADRS) ScoreTime frame: From enrollment to final MADRS score assessment within 2 weeks.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
LGTC Group
San Jose, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.